US3722500A - Abortive device and method - Google Patents

Abortive device and method Download PDF

Info

Publication number
US3722500A
US3722500A US00102448A US3722500DA US3722500A US 3722500 A US3722500 A US 3722500A US 00102448 A US00102448 A US 00102448A US 3722500D A US3722500D A US 3722500DA US 3722500 A US3722500 A US 3722500A
Authority
US
United States
Prior art keywords
substance
uterus
incrustation
abortifacient
cervix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00102448A
Inventor
R Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3722500A publication Critical patent/US3722500A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Definitions

  • one form of the invention after the body is inserted, it is filled with a substance to effect the distension [56] Referen Cited thereof.
  • the body is provided with an incrustation and then charged with a pres- UNITED STATES PATENTS surized substance before insertion.
  • ABORTIVE DEVICE AND METHOD Legalized abortive methods have, for the most part, heretofore been performed by the duly authorized and properly registered physician through use of acurette' or the like in the case of the nonviable embryo and other surgical instruments with respect to the viable fetus.
  • miscarriages for various reasons occur quite frequently, oftentimes without knowledge by the female, particularly within a short period of time following conception.
  • spontaneous expulsion may be caused by health, injury or unknown factors which induce menstruation and resultant discharge of the endometrium, together with the fertilized ovum implanted therein.
  • Another important object of my present invention is to cause naturopathic abortion by virtue of the fact that the uterus tends to expel foreign objects, causing miscarriage, and eliminating the need for surgical discomfort or the risk of ill after effects.
  • Still another object of the present invention is to provide an abortive device which may be easily and quickly inserted into the uterus by the physician, following which the fertilized ovum is expelled through natural process of muscular activity and induced menstruation.
  • FIG. 1 is an elevational view of one type of tubular instrument which may be used to carry out one of the methods of my present invention, illusfiating in phantom a first example of an abortive device which may be inserted thereby;
  • FIG. 2 is an enlarged, fragmentary, longitudinal cross-sectional view of the instrument and device shown in FIG. 1;
  • FIG. 3 is a view similar to FIG. 2, still further enlarged, showing the device projected beyond the tubular portion of the instrument;
  • FIG. 4 is a fragmentary cross-sectional view of a portion of the device and of the proximal end of the plunger of the instrument;
  • FIG. 5 is a' fragmentary cross-sectional view, enlarged still further, of the device after the same is detached from the plunger;
  • FIGS. 6, 7 and 8 are fragmentary cross-sectional views showing the successive steps of inserting the device and its position in the uterus after withdrawal of the instrument from the cervix;
  • FIG. 9 is a cross-sectional view of a modified form of abortive device made pursuant to my present invention.
  • FIG. 10 is an enlarged view of the device of FIG. 9 showing the same within the uterus.
  • FIGS. 1-8 of the drawing there is illustrated an abortifacient (abortion inducing means) denoted by the numeral 10 in the nature of an elongated, hollow body 12 which may be made from a silicone rubber or other essentially nonporous, distensible, elastomeric material capable of preventing escape therefrom of a body-distending substance 14. While the precise shape of the body 12 is of no special importance, ease of insertion into uterus 16 through the cervix l8, and proper fitting of body 12 within the uterus 16 suggests, to some extent at least, choice of the generally elliptical configuration of body 12 as illustrated.
  • the size of the body 12 is not particularly critical, but generally, depending somewhat on the size and condition of the uterus 16 and cervix 18, it may measure from about 1 1% to 2 A inches long and from about 15 to 1 inch in diameter in the uterus 16 after expansion of body 12 by substance 14.
  • the abortive device 10 may be placed in one end of a tube 20 forming part of a manually manipulable tool 22 which is also equipped with a plunger 24.
  • Tool 22 may be further provided with a separate or an integral syringe 26 or other apparatus that includes a cylinder 28 communicating with bore 30 in plunger 24 and having a reciprocable piston 32 used to force the substance 14 from cylinder 28 through bore 30 and into body 12 after the device 10 is disposed the uterus 16 as shown in FIG. 6.
  • plunger 24 In use, the plunger 24 is extended until shoulder'34 engages abutment 36 so as to project nozzle 50 out of the proximal end of tube 20, permitting insertion of nozzle 50 into orifice 52 as seen best in FIG. 4. Plunger 24 isthen retracted to pull the device 10 into the tube 20 as shown in FIGS. 1 and 2. Piston 32 is thereupon removed, cylinder 28 is filled with the substance 14 (FIG. 2) and piston 32 is then replaced as shown in FIG. 1.
  • the body 12 is then charged with the substance 14 by depression of plunger 24, causing the body 12 to expand as shown in FIGS. 3 and 7.
  • the plunger 24 is then retracted until boss 42 engages shoulder 44, causing withdrawal of nozzle 50 from the orifice 52 as the enlarged device 10 is held against movement into the tube 20 by abutment against the proximal end of tube 20.
  • Orifice 52 seals automatically (FIG. 5) trapping the substance 14 within the body 12, whereupon the tube 20 is withdrawn from the cervix 1s and the vagina, leaving the device 10 in the uterus 16 as shown in FIG. 8.
  • the presence of device 10 in the uterus causes natural muscular activity in an effort to expel the device 10 from the uterus 16 through the cervix 18.
  • the size of device is such that expulsion does not occur until the muscular action becomes sufficiently forceful to induce menstruation. This results in shedding of the endometrium of the uterus l6 and its discharge from the cervix 18 along with the fertilized ovum implanted therein as well as the device 10.
  • the wall of body 12 should be sufficiently thin and pliable as to cause it to distend readily under the pressure of the substance 14 forced therein by use of the tool 22 in the manner above described, yet be strong and tough enough to withstand the pressure and not burst.
  • the material chosen for body 12 must be resistant not only to the physical forces of movement into and out of tube 20 but to the extraction of nozzle 50 from within the orifice 52.
  • the elastomeric material from which body 12 is made must be capable of resisting all chemical reaction while subjected to the fluids within the uterus 16 and not in any manner become an irritant to the internal uterus tissues.
  • the abortive device 56 illustratedin FIGS. 9 and 10 includes a body 58 which may have the same characteristics as the body 12 except that it is precoated with an incrustation 60 capable of being softened or dissolved in uterus 62 after insertion of the device 56 thereinto through cervix 64. Moreover, after body 58 is so coated and prior to insertion of device 56 into the uterus 62, body 58 is charged with a pressurized substance which will distend the body 58 after the incrustation 60 has softened or dissolved away, it being understood, of course, that incrustation 60 be capable of preventing distension of body 58 by the substance therein while the incrustation 60 remains in a hardened condition on body 58.
  • a check valve or self-sealing orifice 66 may be provided for the body 58 the same as in the body 12 but the plunger 24 of the insertion tool 22 need not be provided with the bore 30 or the nozzle 50, and there will be no need for syringe 26 if the body 58 is charged with a compressible fluid or the like, such asv air or other elastic gas, before device 56 is loaded into the outer end of tube 20.
  • the pressure of the substance in body 58 should be sufficient only to balloon the body 58, after softening or dissolution of incrustation 60, to approximately the expanded size of body 12 as above specified and as shown in FIGS. 8 and 10, but device 56, prior to insertion, as shown in FIG. 9, should be about the same size as unexpanded device 10 (compare with FIG. 2) for ease of direction through cervix 64.
  • ingredients for the incrustation 60 will assure its softening by body heat of the patient and/0r dissolution by the uterus fluids, sufficient to release body 58 for expansion by the compressed substance precharged therein, all without/injury or harmful effects to the patient.
  • Such ingredients may include an admixture of a filler, a binder for increasing the strength and cohesive properties of incrustation 60, and a disintegrating agent for increasing its speed of solution.
  • Powdered milk, powdered cocoa, or sugar may be used as the filler, whereas the binder may be selected from glucose, an acacia or gelatine solution, a heavy sugar syrup, or a starch paste. Lactose may also be used to serve both as a filler and as a binder. If a disintegrating agent is believed necessary or desirable, the use of corn or potato starch will make it unnecessary to rely entirely on the heat of uterus 62 to release body 58 for expansion as shown in FIG..10.
  • An abortifacient comprising:
  • said body containing a substance when the body is in the uterus capable of distending the body to a size sufficient to induce menstruation
  • said substance being expansible, said body having an incrustation normally holding the body against distension by said substance, said incrustation softening in the uterus to release the body for distension by the substance.
  • a method of terminating pregnancy prematurely which comprises insertion of an essentially nonporous, distensible hollow body of elastomeric material into the uterus through the cervix, said body containing a substance when the body is in the uterus capable of distending the body to a size sufficient to induce menstruation, said substance being expansible and being directed into the body under pressure before the latter is inserted into the uterus, said body prior to having the substance directed thereinto being provided with an incrustation which softens when the body is in the uterus, said incrustation holding the body against distension by said substance until the incrustation softens.
  • a method of terminating pregnancy prematurely comprising the steps of:

Abstract

Premature termination of pregnancy is effected by insertion of a hollow, distensible body of elastomeric material into the uterus to stimulate muscular activity sufficiently to induce menstruation and thereby cause spontaneous expulsion of the nonviable embryo. In one form of the invention, after the body is inserted, it is filled with a substance to effect the distension thereof. In another embodiment, the body is provided with an incrustation and then charged with a pressurized substance before insertion. The incrustation dissolves in the uterus, permitting the substance to expand and distend the body to a size which precludes its expulsion until shedding of the endometrium and discharge of the implantation therewith.

Description

0 United States Patent 1 1 1111 3,722,500
Robinson 1 Mar. 27, 1973 [54] ABORTIVE DEVICE AND METHOD [76] Inventor: Ralph R. Robinson, PO. Box 668, f,
Middlesboro, 40965 Attorney-Schmidt, Johnson, Hovey & W1ll1ams [22] Filed: Dec. 29, 1970 57 ABSTRACT PP N03 102,448 Premature termination of pregnancy is effected by insertion of a hollow, distensible body of elastomeric 52 US. 01. ..12s/1 R material into the uterus to stimulate muscular activity 51 1m. 01. ..A61b 19/00, A6lf 5/46 snfficinnflyv o induce menstruation and thereby cause 58 Field of Search ..128/1 R, 127, 129, 130,131, Spontaneous expulsion of the nonviable y In 123 344 one form of the invention, after the body is inserted, it is filled with a substance to effect the distension [56] Referen Cited thereof. In another embodiment, the body is provided with an incrustation and then charged with a pres- UNITED STATES PATENTS surized substance before insertion. The incrustation 3,464,409 9/1969 Murphy ..l28/l29 dissolves in the mus, Pflmming the Substance 3,452,749 7/1969 Riedell ....12s/129 P and distend the y to a Size which precludes 3,401,689 9/1968 Greenwood ..128/129 its expulsion until shedding of the endometrium and 3,512,528 5/1970 Whitehead et al..... ....l28/l29 X discharge of the implantation therewith. 2,063,202 12/1936 Spicer ..l28/l30 2,893,385 7/1959 Millar...... ....l28/l31 9 Claims, 10 Drawing Figures PATENTEDMAR 27 I973 INVENTOR. ph R. RObI/730I7 T NE Y8.
ABORTIVE DEVICE AND METHOD Legalized abortive methods have, for the most part, heretofore been performed by the duly authorized and properly registered physician through use of acurette' or the like in the case of the nonviable embryo and other surgical instruments with respect to the viable fetus. On the other hand, miscarriages for various reasons occur quite frequently, oftentimes without knowledge by the female, particularly within a short period of time following conception. Such spontaneous expulsion may be caused by health, injury or unknown factors which induce menstruation and resultant discharge of the endometrium, together with the fertilized ovum implanted therein.
It is an important object of the instant invention, therefore, to provide the doctor with a safe and simple, yet effective means for duplicating such premature expulsion of the nonviable embryo during the early stages of pregnancy without need for the usual uterus scraping procedures or any other type of surgical techniques.
Another important object of my present invention is to cause naturopathic abortion by virtue of the fact that the uterus tends to expel foreign objects, causing miscarriage, and eliminating the need for surgical discomfort or the risk of ill after effects.
Still another object of the present invention is to provide an abortive device which may be easily and quickly inserted into the uterus by the physician, following which the fertilized ovum is expelled through natural process of muscular activity and induced menstruation.
In the drawing:
FIG. 1 is an elevational view of one type of tubular instrument which may be used to carry out one of the methods of my present invention, illusfiating in phantom a first example of an abortive device which may be inserted thereby;
FIG. 2 is an enlarged, fragmentary, longitudinal cross-sectional view of the instrument and device shown in FIG. 1;
FIG. 3 is a view similar to FIG. 2, still further enlarged, showing the device projected beyond the tubular portion of the instrument;
FIG. 4 is a fragmentary cross-sectional view of a portion of the device and of the proximal end of the plunger of the instrument;
FIG. 5 is a' fragmentary cross-sectional view, enlarged still further, of the device after the same is detached from the plunger;
FIGS. 6, 7 and 8 are fragmentary cross-sectional views showing the successive steps of inserting the device and its position in the uterus after withdrawal of the instrument from the cervix;
FIG. 9 is a cross-sectional view of a modified form of abortive device made pursuant to my present invention; and
FIG. 10 is an enlarged view of the device of FIG. 9 showing the same within the uterus.
In FIGS. 1-8 of the drawing there is illustrated an abortifacient (abortion inducing means) denoted by the numeral 10 in the nature of an elongated, hollow body 12 which may be made from a silicone rubber or other essentially nonporous, distensible, elastomeric material capable of preventing escape therefrom of a body-distending substance 14. While the precise shape of the body 12 is of no special importance, ease of insertion into uterus 16 through the cervix l8, and proper fitting of body 12 within the uterus 16 suggests, to some extent at least, choice of the generally elliptical configuration of body 12 as illustrated. Moreover, the size of the body 12 is not particularly critical, but generally, depending somewhat on the size and condition of the uterus 16 and cervix 18, it may measure from about 1 1% to 2 A inches long and from about 15 to 1 inch in diameter in the uterus 16 after expansion of body 12 by substance 14.
For insertion purpose, and by way of example, the abortive device 10 may be placed in one end of a tube 20 forming part of a manually manipulable tool 22 which is also equipped with a plunger 24. Tool 22 may be further provided with a separate or an integral syringe 26 or other apparatus that includes a cylinder 28 communicating with bore 30 in plunger 24 and having a reciprocable piston 32 used to force the substance 14 from cylinder 28 through bore 30 and into body 12 after the device 10 is disposed the uterus 16 as shown in FIG. 6.
Shoulder 34 on cylinder 28 engages abutment 36 on enlarged portion 38 of tube 20 to indicate that the device 10 has been fully ejected from the tube 20, whereupon the doctor uses finger tabs 40 on cylinder 28 to facilitate depression of thumb piece 41 on piston 32. Boss 42 on plunger 24 engages shoulder 44 in portion 38 of tube 20 to limit the extent of retraction of plunger 24. Ribs 46 and 48 on tube 20 and piston 32 respectively slide within corresponding grooves (not shown) in portion 38 and cylinder 28 respectively to prevent relative rotation of the component parts of the tool 22. Plunger 24 terminates in a short nozzle 50 that fits within an orifice provided with a check valve or a self-sealing orifice 52 in that end of the body 12 which abuts a shoulder 54 on plunger 24.
In use, the plunger 24 is extended until shoulder'34 engages abutment 36 so as to project nozzle 50 out of the proximal end of tube 20, permitting insertion of nozzle 50 into orifice 52 as seen best in FIG. 4. Plunger 24 isthen retracted to pull the device 10 into the tube 20 as shown in FIGS. 1 and 2. Piston 32 is thereupon removed, cylinder 28 is filled with the substance 14 (FIG. 2) and piston 32 is then replaced as shown in FIG. 1.
The physician thereupon inserts the tube 20 through the vagina (not shown) and into the cervix 18, following which he depresses the plunger 24 until shoulder 34 engages the abutment 36 to fully eject the device 10 into the uterus 16 as shown in FIG. 6. g I
The body 12 is then charged with the substance 14 by depression of plunger 24, causing the body 12 to expand as shown in FIGS. 3 and 7. The plunger 24 is then retracted until boss 42 engages shoulder 44, causing withdrawal of nozzle 50 from the orifice 52 as the enlarged device 10 is held against movement into the tube 20 by abutment against the proximal end of tube 20.
Orifice 52 seals automatically (FIG. 5) trapping the substance 14 within the body 12, whereupon the tube 20 is withdrawn from the cervix 1s and the vagina, leaving the device 10 in the uterus 16 as shown in FIG. 8.
As is well known, the presence of device 10 in the uterus causes natural muscular activity in an effort to expel the device 10 from the uterus 16 through the cervix 18. The size of device is such that expulsion does not occur until the muscular action becomes sufficiently forceful to induce menstruation. This results in shedding of the endometrium of the uterus l6 and its discharge from the cervix 18 along with the fertilized ovum implanted therein as well as the device 10.
lt follows then that the wall of body 12 should be sufficiently thin and pliable as to cause it to distend readily under the pressure of the substance 14 forced therein by use of the tool 22 in the manner above described, yet be strong and tough enough to withstand the pressure and not burst. Moreover, the material chosen for body 12 must be resistant not only to the physical forces of movement into and out of tube 20 but to the extraction of nozzle 50 from within the orifice 52. Still further, the elastomeric material from which body 12 is made must be capable of resisting all chemical reaction while subjected to the fluids within the uterus 16 and not in any manner become an irritant to the internal uterus tissues.
Consideration should also be given to proper choice of the substance 14 such that no deleterious chemical reaction will occur between the material chosen for body 12 and the substance 14 used for its distension. Many types of fluids may be used but a weak saline solution or other liquid is satisfactory because there should be no risk of injury to the patient in the event of accidental spillage by the doctor or leakage from the body 12.
The abortive device 56 illustratedin FIGS. 9 and 10 includes a body 58 which may have the same characteristics as the body 12 except that it is precoated with an incrustation 60 capable of being softened or dissolved in uterus 62 after insertion of the device 56 thereinto through cervix 64. Moreover, after body 58 is so coated and prior to insertion of device 56 into the uterus 62, body 58 is charged with a pressurized substance which will distend the body 58 after the incrustation 60 has softened or dissolved away, it being understood, of course, that incrustation 60 be capable of preventing distension of body 58 by the substance therein while the incrustation 60 remains in a hardened condition on body 58.
A check valve or self-sealing orifice 66 may be provided for the body 58 the same as in the body 12 but the plunger 24 of the insertion tool 22 need not be provided with the bore 30 or the nozzle 50, and there will be no need for syringe 26 if the body 58 is charged with a compressible fluid or the like, such asv air or other elastic gas, before device 56 is loaded into the outer end of tube 20.
The pressure of the substance in body 58 should be sufficient only to balloon the body 58, after softening or dissolution of incrustation 60, to approximately the expanded size of body 12 as above specified and as shown in FIGS. 8 and 10, but device 56, prior to insertion, as shown in FIG. 9, should be about the same size as unexpanded device 10 (compare with FIG. 2) for ease of direction through cervix 64.
Proper selection of the ingredients for the incrustation 60 will assure its softening by body heat of the patient and/0r dissolution by the uterus fluids, sufficient to release body 58 for expansion by the compressed substance precharged therein, all without/injury or harmful effects to the patient. Such ingredients may include an admixture of a filler, a binder for increasing the strength and cohesive properties of incrustation 60, and a disintegrating agent for increasing its speed of solution.
Powdered milk, powdered cocoa, or sugar (powdered or granular) may be used as the filler, whereas the binder may be selected from glucose, an acacia or gelatine solution, a heavy sugar syrup, or a starch paste. Lactose may also be used to serve both as a filler and as a binder. If a disintegrating agent is believed necessary or desirable, the use of corn or potato starch will make it unnecessary to rely entirely on the heat of uterus 62 to release body 58 for expansion as shown in FIG..10.
While it is not contemplated that the devices or methods above described will necessarily be satisfactory in an effort to efifect miscarriage of the viable fetus beyond the first 12 to 28 weeks of gestation, its use to induce abortion of the nonviable embryo during at least the first 8 weeks of pregnancy will, in most cases, cause no ill effects and constitute a decided improvement over devices and methods heretofore used or suggested.
Having thus described the invention, what is claimed as new and desired to be secured by Letters Patent is:
1. An abortifacient comprising:
an essentially nonporous, distensible hollow body of elastomeric material insertable into the uterus through the cervix,
said body containing a substance when the body is in the uterus capable of distending the body to a size sufficient to induce menstruation,
said substance being expansible, said body having an incrustation normally holding the body against distension by said substance, said incrustation softening in the uterus to release the body for distension by the substance.
2. An abortifacient as claimed in claim 1 wherein said substance is a compressible fluid.
3. An abortifacient as claimed in claim 1, said body being provided with a self-sealing orifice through which said substance may be directed after the incrustation is placed thereon. i
4. An abortifacient as claimed in claim 1 wherein said incrustation contains a binder for increasing its strength and cohesive properties.
5. An abortifacient as claimed in claim 1 wherein said incrustation contains a disintegrating agent for increasing the speed of solution.
6. An abortifacient as claimed in claim 1 wherein said incrustation comprises an admixture of a filler, a binder and a disintegrating agent.
7. A method of terminating pregnancy prematurely which comprises insertion of an essentially nonporous, distensible hollow body of elastomeric material into the uterus through the cervix, said body containing a substance when the body is in the uterus capable of distending the body to a size sufficient to induce menstruation, said substance being expansible and being directed into the body under pressure before the latter is inserted into the uterus, said body prior to having the substance directed thereinto being provided with an incrustation which softens when the body is in the uterus, said incrustation holding the body against distension by said substance until the incrustation softens.
8. A method of terminating pregnancy prematurely comprising the steps of:
6 inserting anessentially nonporous, distensible hollow condition from the uterus through the cervix by body into the uterus through the cervix; the force of said uterine muscular activity during injecting a predetermined amount of substance into e ndu enstruat on.
said body when the latter is in the uterus to distend The m th l ime in clairn 8, herein the the body to a size sufficient to induce muscular ac- 5 Substance l l f mm 831d f y llmlted to an tivity of such magnitude as to cause menstruation; f F whlch W111 Produce a m of from to l and ll'lCh 1n the body when the latter is fully distended. expelling the body while still in its fully distended

Claims (8)

  1. 2. An abortifacient as claimed in claim 1 wherein said substance is a compressible fluid.
  2. 3. An abortifacient as claimed in claim 1, said body being provided with a self-sealing orifice through which said substance may be directed after the incrustation is placed thereon.
  3. 4. An abortifacient as claimed in claim 1 wherein said incrustation contains a binder for increasing its strength and cohesive properties.
  4. 5. An abortifacient as claimed in claim 1 wherein said incrustation contains a disintegrating agent for increasing the speed of solution.
  5. 6. An abortifacient as claimed in claim 1 wherein said incrustation comprises an admixture of a filler, a binder and a disintegrating agent.
  6. 7. A method of terminating pregnancy prematurely which comprises insertion of an essentially nonporous, distensible hollow body of elastomeric material into the uterus through the cervix, said body containing a substance when the body is in the uterus capable of distending the body to a size sufficient to induce menstruation, said substance being expansible and being directed into the body under pressure before the latter is inserted into the uterus, said body prior to having the substance directed thereinto being provided with an incrustation which softens when the body is in the uterus, said incrustation holding the body against distension by said substance until the incrustation softens.
  7. 8. A method of terminating pregnancy prematurely comprising the steps of: inserting an essentially nonporous, distensible hollow body into the uterus through the cervix; injecting a predetermined amount of substance into said body when the latter is in the uterus to distend the body to a size sufficient to induce muscular activity of such magnitude as to cause menstruation; and expelling the body while still in its fully distended condition from the uterus through the cervix by the force of said uterine muscular activity during the induced menstruation.
  8. 9. The method as claimed in claim 8, wherein the substance injected into said body is limited to an amount which will produce a maximum of from 1/2 to 1 inch in the body when the latter is fully distended.
US00102448A 1970-12-29 1970-12-29 Abortive device and method Expired - Lifetime US3722500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10244870A 1970-12-29 1970-12-29

Publications (1)

Publication Number Publication Date
US3722500A true US3722500A (en) 1973-03-27

Family

ID=22289898

Family Applications (1)

Application Number Title Priority Date Filing Date
US00102448A Expired - Lifetime US3722500A (en) 1970-12-29 1970-12-29 Abortive device and method

Country Status (3)

Country Link
US (1) US3722500A (en)
GB (1) GB1343938A (en)
SE (1) SE386587B (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3848602A (en) * 1972-04-19 1974-11-19 Gutnick Morton Abortion facilitating device and process
US4237893A (en) * 1979-11-28 1980-12-09 Alza Corporation Cervical dilator
EP0105669A1 (en) * 1982-09-30 1984-04-18 Beta Phase Inc. Method of contraception and apparatus for carrying out such method
US4686962A (en) * 1986-07-03 1987-08-18 Habley Medical Technology Corporation Disposable cartridge assembly for hypodermically implanting a genitourinary prosthesis
EP0268108A1 (en) * 1986-10-31 1988-05-25 C.R. Bard, Inc. Hand-held instrument for implanting, dispensing, and inflating an inflatable membrane
EP0401822A2 (en) * 1989-06-08 1990-12-12 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical preparation administrator
WO1991009578A1 (en) * 1990-01-03 1991-07-11 Gerald Wolf Method and apparatus for reversibly occluding a biological tube
US6679266B2 (en) 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6684884B2 (en) 1995-06-07 2004-02-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
WO2008047398A2 (en) * 2006-10-20 2008-04-24 Germedia S.R.L. Insert for treating human or animal body cavities, in particular ear cavities
US20110184349A1 (en) * 2010-01-27 2011-07-28 Warsaw Orthopedic, Inc. Drug dispensing balloon for treating disc disease or pain

Cited By (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3848602A (en) * 1972-04-19 1974-11-19 Gutnick Morton Abortion facilitating device and process
US4237893A (en) * 1979-11-28 1980-12-09 Alza Corporation Cervical dilator
EP0105669A1 (en) * 1982-09-30 1984-04-18 Beta Phase Inc. Method of contraception and apparatus for carrying out such method
US4686962A (en) * 1986-07-03 1987-08-18 Habley Medical Technology Corporation Disposable cartridge assembly for hypodermically implanting a genitourinary prosthesis
WO1988000028A1 (en) * 1986-07-03 1988-01-14 Habley Medical Technology Corporation Assembly for hypodermically implanting a genitourinary prosthesis
EP0268108A1 (en) * 1986-10-31 1988-05-25 C.R. Bard, Inc. Hand-held instrument for implanting, dispensing, and inflating an inflatable membrane
EP0401822A2 (en) * 1989-06-08 1990-12-12 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical preparation administrator
EP0401822A3 (en) * 1989-06-08 1991-03-20 Sumitomo Pharmaceuticals Company, Limited Pharmaceutical preparation administrator
US5171219A (en) * 1989-06-08 1992-12-15 Sumitomo Pharmaceuticals Co., Ltd. Pharmaceutical preparation administrator
WO1991009578A1 (en) * 1990-01-03 1991-07-11 Gerald Wolf Method and apparatus for reversibly occluding a biological tube
US20060144406A1 (en) * 1995-06-07 2006-07-06 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US7428904B2 (en) 1995-06-07 2008-09-30 Alien Technology Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040079377A1 (en) * 1995-06-07 2004-04-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20040127918A1 (en) * 1995-06-07 2004-07-01 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US20040159324A1 (en) * 1995-06-07 2004-08-19 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040163651A1 (en) * 1995-06-07 2004-08-26 Conceptus, Inc. Transcervical fallopian tube occlusion devices and their delivery
US20040206358A1 (en) * 1995-06-07 2004-10-21 Conceptus, Inc., A California Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20040211429A1 (en) * 1995-06-07 2004-10-28 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6679266B2 (en) 1995-06-07 2004-01-20 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20070000496A1 (en) * 1995-06-07 2007-01-04 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US20070044808A1 (en) * 1995-06-07 2007-03-01 Conceptus, Inc., A California Corporation Contraceptive transcervical fallopian tube occlusion devices and their delivery
US20070062542A1 (en) * 1995-06-07 2007-03-22 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US20070144528A1 (en) * 1995-06-07 2007-06-28 Julian Nikolchev Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8733361B2 (en) 1995-06-07 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US8356599B2 (en) 1995-06-07 2013-01-22 Conceptus, Inc. Occlusion devices and methods
US6684884B2 (en) 1995-06-07 2004-02-03 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US7686020B2 (en) 1995-06-07 2010-03-30 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8327852B2 (en) 1995-06-07 2012-12-11 Conceptus, Inc. Occlusion devices and methods
US20110030696A1 (en) * 1995-06-07 2011-02-10 Nikolchev Julian N Contraceptive transcervical fallopian tube occlusion devices and methods
US7921848B2 (en) 1995-06-07 2011-04-12 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8171936B2 (en) 1995-06-07 2012-05-08 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US8066007B2 (en) 1995-06-07 2011-11-29 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US8613282B2 (en) 1997-09-24 2013-12-24 Conceptus, Inc. Occlusion devices and methods
US8733360B2 (en) 1997-09-24 2014-05-27 Bayer Essure Inc. Occlusion devices and methods
US20100312198A1 (en) * 2006-10-20 2010-12-09 Gianmaria Guidi Insert for treating human or animal body cavities, in particular ear cavities
WO2008047398A3 (en) * 2006-10-20 2008-06-12 Germedia S R L Insert for treating human or animal body cavities, in particular ear cavities
WO2008047398A2 (en) * 2006-10-20 2008-04-24 Germedia S.R.L. Insert for treating human or animal body cavities, in particular ear cavities
US20110184349A1 (en) * 2010-01-27 2011-07-28 Warsaw Orthopedic, Inc. Drug dispensing balloon for treating disc disease or pain
US8864711B2 (en) * 2010-01-27 2014-10-21 Warsaw Orthopedic, Inc. Drug dispensing balloon for treating disc disease or pain

Also Published As

Publication number Publication date
GB1343938A (en) 1974-01-16
SE386587B (en) 1976-08-16

Similar Documents

Publication Publication Date Title
USRE29207E (en) Dispensing method and apparatus
US3572335A (en) Cervical implant method and device
US5299581A (en) Intravaginal device
JP4764432B2 (en) System for placing material on bone
US3722500A (en) Abortive device and method
US3822702A (en) Dispensing method and apparatus
US3858571A (en) Cornual plug
US3848602A (en) Abortion facilitating device and process
US3871374A (en) Dispensing instrument
US4424054A (en) Fluid-expansible contraceptive tampon and applicator
US3522803A (en) Inserter for intra-uterine device
US3948259A (en) Dispensing instrument
US3805767A (en) Method and apparatus for non-surgical, reversible sterilization of females
US3972331A (en) Dispensing catheter
US4182328A (en) Dispensing instrument and method
US11020574B2 (en) Disposable gynecologic instrument for dilation of body cavities by fluid injection
RU2003118327A (en) APPLICATOR FOR FEEDING VOLUME DEVICES
US11382799B2 (en) Tampon with intravaginal cannabinoid delivery device
CN202776442U (en) Packing device for treating uterine bleeding
CN111032139A (en) Postpartum hemorrhage balloon system
US3157180A (en) Catamenial receptacle
HU180047B (en) Apparatus for moving in materials into the tuba vterina
US3823715A (en) Suppository introducer
US3828781A (en) Method for withdrawing menstrual fluid
CN113056245A (en) Menstrual fluid removal